dipyridamole has been researched along with Brain Vascular Disorders in 172 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Conditions characterized by a reduction in platelet survival and where dipyridamole has been used include heart valve replacement, arterial grafting, cerebrovascular disorders, and disorders of peripheral circulation." | 6.15 | Dipyridamole: a critical evaluation. ( Alexander, MR; Rivey, MP; Taylor, JW, 1984) |
| "We compared the outcomes of 2,500 patients who suffered from previous cerebrovascular disorders (transient ischemic attacks, reversible ischemic neurologic deficits, or completed strokes) treated with acetylsalicylic acid plus dipyridamole or matched placebo and followed for 2 years." | 5.06 | European Stroke Prevention Study. ESPS Group. ( , 1990) |
| "The efficacy and safety of a combination of Persantine and aspirin, of aspirin alone and of a placebo as a regimen for preventing reinfarction were compared in 2026 patients who had recovered from a documented acute myocardial infarction (MI) that had occurred 8 weeks to 5 years previously." | 5.05 | The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group. ( , 1980) |
| " These trials were prompted by earlier observations that aspirin takers seemed to fare better after acute myocardial infarction and were further stimulated by the recent growth of knowledge about the role of vascular and platelet prostaglandins." | 5.05 | Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials. ( Castaldi, PA, 1981) |
| " centers, 231 male diabetic patients who had either a recent amputation for gangrene (N = 207) or active gangrene (N = 24) were randomly assigned to a group which received aspirin (325 mg t." | 5.05 | V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics. ( Abraira, C; Anderson, JW; Bingham, SF; Colwell, JA; Kwaan, HC, 1985) |
| "Using the key terms acute coronary syndrome, atherothrombosis, ischemic stroke, myocardial infarction, MI, peripheral arterial disease, TIA, transient ischemic attack, unstable angina,aspirin,ticlopidine,dipyridamole, and clopidogrel, we searched the MEDLINE database as well as the trial register of the Cochrane Groups to identify studies published from 1960 to August 2004." | 4.82 | Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. ( Anand, SS; Tran, H, 2004) |
| " The search terms used were dipyridamole, aspirin, acetylsalicylic acid, ischemic stroke, and cerebrovascular disorders." | 4.81 | Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke. ( Redman, AR; Ryan, GJ, 2001) |
| "Our findings do not concur with the hypothesis that aspirin, dipyridamole, or the combination may be especially effective in preventing vascular events in patients with previous cerebral ischemia that was caused by LVD compared with SVD." | 3.73 | Antiplatelet drugs in the secondary prevention after stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2. ( Algra, A; Ariesen, MJ; Kappelle, LJ, 2006) |
| " Moreover, patients without any history of coronary heart disease and showing a normal resting ECG underwent a bicycle exercise test or a dipyridamole thallium scintigraphy to detect possible silent myocardial ischemia." | 3.69 | Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM. ( Brun, JM; Cohen, M; Gambert, P; Lagrost, L; Petit, JM; Vaillant, G; Vergès, BL, 1997) |
| "Anti-platelet therapy (Aspirin 250 mg/every other day approximately 1000 mg/day + Dipyridamole 150 mg/day) was performed on 51 patients with ischemic cerebrovascular disorders (ICVD)." | 3.67 | [Anti-platelet therapy in ischemic cerebrovascular disorder--clinical and hematological study]. ( Aiba, T; Seki, Y; Shiozawa, R; Tsukada, T; Yoshii, K, 1985) |
| "Dipyridamole was associated with a slight increase in headache, which resolved in most patients if therapy was continued." | 2.69 | Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study. ( Forbes, CD, 1998) |
| "Patients with prior stroke or transient ischemic attack (TIA) were randomized to treatment with ASA alone (50 mg daily), modified-release dipyridamole alone (400 mg daily), the two agents in a combined formulation, or placebo." | 2.68 | European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. ( Cunha, L; Diener, HC; Forbes, C; Lowenthal, A; Sivenius, J; Smets, P, 1996) |
| "Only aspirin has been evaluated in the setting of primary prevention and it seems to be ineffective in preventing cerebral infarction." | 2.68 | [Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors]. ( Canaple, S; Rosa, A, 1996) |
| "Seven of nine patients (78%) developed thrombus; five had thrombus visible within the clear housing of the device during the implant period, and two patients had thrombus discovered only after VAD explantation." | 2.66 | Thromboembolic complications of the Symbion AVAD System. ( Cleavinger, M; Copeland, JG; Icenogle, TB; Sethi, GK; Smith, RG; Vasu, MA; Williams, RJ, 1989) |
| " Ticlopidine has been proven to be more effective than aspirin, but its potentially serious side effect profile makes long-term use hazardous." | 2.41 | Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. ( Bhatt, DL; Kapadia, SR; Topol, EJ; Yadav, JS, 2000) |
| "Dipyridamole is a useful agent in 'pharmacological stress' testing in nuclear cardiology imaging and may be valuable when combined with warfarin in certain patient groups, such as those with prosthetic heart valves." | 2.40 | Do we still need dipyridamole? ( Gibbs, CR; Lip, GY, 1998) |
| "Ticlopidine has been widely used in patients with a high risk of stroke who are sensitive to aspirin or in whom aspirin has failed." | 2.40 | Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease. ( Harbison, JW, 1998) |
| " This review article examines research on both monotherapy and combination antiplatelet therapy for secondary stroke prevention, with an emphasis on lessons learned about dosage schedules, treatment protocols, and side-effect profiles." | 2.40 | Antiplatelet therapy for secondary stroke prevention. ( Forbes, CD, 1999) |
| " Acetylsalicylic acid is the first choice medical treatment, but the optimal dosage is still a matter of debate." | 2.39 | [Large trials in the secondary prevention of stroke]. ( Gensini, GF; Inzitari, D; Pantoni, L; Simone, I, 1996) |
| "Ticlopidine was more effective than aspirin in reducing stroke in both males and females." | 2.38 | Antiplatelet therapy in the prevention of stroke. ( Easton, JD, 1991) |
| "However, their effects on thrombus formation have rarely been evaluated in experimental animals in vivo." | 1.29 | In vivo evaluation of antiplatelet agents in gerbil model of carotid artery thrombosis. ( Iwamoto, Y; Naritomi, H; Nishimura, H; Sugita, M; Tachibana, H, 1996) |
| "Aspirin was used by 91 physicians (36." | 1.28 | Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. ( Kutner, M; Nixon, G; Silverstone, F, 1991) |
| "Aspirin/dipyridamole-treated patients failed to show suppression of platelet activating factor-induced platelet aggregation even though collagen-induced activation was inhibited, suggesting that platelet activating factor acts by cyclooxygenase-independent mechanisms." | 1.28 | Effect of therapy on platelet activating factor-induced aggregation in acute stroke. ( D'Andrea, G; Joseph, R; Welch, KM, 1989) |
| "In patients with transient ischemic attack (TIA), the risk of stroke increases greatly, especially in the months immediately following the initial attack." | 1.27 | Transient ischemic attacks. Strategies for minimizing stroke risk. ( Furlan, AJ, 1984) |
| "Recurrent transient ischemic attack or amaurosis fugax occurred more frequently (P less than 0." | 1.27 | Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks. ( Eriksson, SE, 1985) |
| "Eight patients with transient ischemic attacks, and three with partial nonprogressive strokes associated with mitral valve prolapse, are reported." | 1.26 | TIA, stroke, and mitral valve prolapse. ( Watson, RT, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 94 (54.65) | 18.7374 |
| 1990's | 63 (36.63) | 18.2507 |
| 2000's | 13 (7.56) | 29.6817 |
| 2010's | 2 (1.16) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algra, A | 10 |
| De Schryver, EL | 6 |
| Halkes, PH | 1 |
| Kössler, J | 1 |
| Steigerwald, U | 1 |
| Walter, U | 1 |
| Gebel, JM | 1 |
| Weber, R | 1 |
| Brenck, J | 1 |
| Diener, HC | 6 |
| van Gijn, J | 6 |
| Tran, H | 1 |
| Anand, SS | 1 |
| Bernstein, RA | 1 |
| Albers, GW | 1 |
| Ariesen, MJ | 1 |
| Kappelle, LJ | 1 |
| Habib, GB | 1 |
| Genton, E | 4 |
| Kelton, JG | 1 |
| Tullio, D | 1 |
| Buckler, P | 1 |
| Douglas, AS | 2 |
| Webster, J | 1 |
| Stewart, ME | 1 |
| Douglas, JT | 1 |
| Lowe, GD | 1 |
| Prentice, CR | 1 |
| Forbes, CD | 5 |
| Sherry, S | 1 |
| Bousser, MG | 3 |
| Eschwège, E | 2 |
| Haguenau, M | 2 |
| Lefauconnier, JM | 2 |
| Thibult, N | 1 |
| Touboul, D | 1 |
| Touboul, PJ | 1 |
| Guiraud-Chaumeil, B | 1 |
| Wilkerson, RJ | 1 |
| Liem, PH | 1 |
| Carter, WJ | 1 |
| Lechner, H | 1 |
| Ott, E | 1 |
| Bertha, G | 1 |
| Kistler, JP | 1 |
| Ropper, AH | 1 |
| Heros, RC | 1 |
| Eichner, ER | 1 |
| Barnett, HJ | 2 |
| Rivey, MP | 1 |
| Alexander, MR | 1 |
| Taylor, JW | 1 |
| Rushton, FW | 1 |
| Kukora, JS | 1 |
| Donaldson, IM | 1 |
| Bouchier-Hayes, D | 1 |
| Pagano, T | 1 |
| Nair, CK | 1 |
| Sketch, MH | 1 |
| Furlan, AJ | 1 |
| Polli, EE | 1 |
| Cortellaro, M | 1 |
| Held, K | 1 |
| Yeung Laiwah, AC | 1 |
| Poliwoda, H | 1 |
| Birgens, HS | 1 |
| Hansen, MS | 1 |
| Passamani, ER | 1 |
| Hirsh, J | 6 |
| Fuster, V | 5 |
| Chesebro, JH | 1 |
| Cristol, R | 1 |
| Olivella, J | 1 |
| Vicens, B | 1 |
| Turpie, AG | 2 |
| Castaldi, PA | 1 |
| Meloche, JP | 1 |
| Cauchie, C | 1 |
| Yatsu, FM | 1 |
| Sivenius, J | 11 |
| Riekkinen, PJ | 6 |
| Laakso, M | 9 |
| Lette, J | 2 |
| Carini, G | 1 |
| Tatum, JL | 1 |
| Paquet, N | 1 |
| Bisson, G | 1 |
| Picard, M | 1 |
| Bom, HS | 1 |
| Lusa, AM | 2 |
| Labanti, G | 2 |
| Teitelbaum, J | 1 |
| Schechter, D | 1 |
| Bocher, M | 1 |
| Berlatzky, Y | 1 |
| Anner, H | 1 |
| Argov, Z | 1 |
| Beer, G | 1 |
| Krausz, Y | 1 |
| Gotsman, MS | 1 |
| Chisin, R | 1 |
| Lowenthal, A | 8 |
| Buyse, M | 1 |
| Ben-Hur, T | 1 |
| Whiting, JH | 1 |
| Datz, FL | 1 |
| Gabor, FV | 1 |
| Jones, SR | 1 |
| Morton, KA | 1 |
| Smets, P | 6 |
| Franck, G | 1 |
| Ferguson, JJ | 1 |
| Nishimura, H | 1 |
| Naritomi, H | 1 |
| Iwamoto, Y | 1 |
| Tachibana, H | 1 |
| Sugita, M | 1 |
| Meldrum, HE | 1 |
| Vergès, BL | 1 |
| Lagrost, L | 1 |
| Vaillant, G | 1 |
| Petit, JM | 1 |
| Cohen, M | 1 |
| Gambert, P | 1 |
| Brun, JM | 1 |
| Cunha, L | 2 |
| Forbes, C | 2 |
| Enserink, M | 1 |
| Gensini, GF | 1 |
| Simone, I | 1 |
| Pantoni, L | 1 |
| Inzitari, D | 2 |
| Barer, D | 1 |
| Barner, A | 1 |
| Rosa, A | 1 |
| Canaple, S | 1 |
| Humphreys, DM | 1 |
| Vickerson, F | 1 |
| Rosendaal, FR | 1 |
| Picano, E | 1 |
| Abbracchio, MP | 1 |
| Gibbs, CR | 2 |
| Li-Saw-Hee, FL | 1 |
| Lip, GY | 2 |
| Puranen, J | 2 |
| Riekkinen, P | 3 |
| Koudstaal, PJ | 1 |
| Gorter, JW | 2 |
| Kurz, X | 1 |
| Annemans, L | 1 |
| Dresse, A | 1 |
| Boysen, G | 1 |
| Tijssen, JG | 1 |
| Bentsen, N | 1 |
| Harbison, JW | 1 |
| Dyken, ML | 1 |
| Zielinski, R | 1 |
| French, L | 1 |
| Wilterdink, JL | 1 |
| Easton, JD | 2 |
| Almdal, TP | 1 |
| Eldrup, E | 1 |
| Godtfredsen, J | 1 |
| Kofoed-Enevoldsen, A | 1 |
| Cohen, SN | 1 |
| Bhatt, DL | 1 |
| Kapadia, SR | 1 |
| Yadav, JS | 1 |
| Topol, EJ | 1 |
| Heidebrink, JL | 1 |
| Redman, AR | 1 |
| Ryan, GJ | 1 |
| Dougherty, JH | 1 |
| Levy, DE | 1 |
| Weksler, BB | 1 |
| Rubegni, M | 2 |
| Provvedi, D | 2 |
| Bellini, PG | 1 |
| Bandinelli, C | 1 |
| De Mauro, G | 1 |
| Didisheim, P | 3 |
| Dettori, AG | 1 |
| Pini, M | 1 |
| Quintavalla, R | 1 |
| Mitchell, JR | 1 |
| Ostendorf, P | 1 |
| Gantmacher, ML | 1 |
| Fields, WS | 1 |
| Watson, RT | 1 |
| Harker, LA | 4 |
| Gent, M | 3 |
| Aledort, LM | 1 |
| Porter, JM | 1 |
| Goodnight, SH | 1 |
| Corn, M | 1 |
| Gotshall, RA | 1 |
| Browder, A | 1 |
| Browder, J | 1 |
| Urbinati, S | 1 |
| Di Pasquale, G | 1 |
| Andreoli, A | 1 |
| Lanzino, G | 1 |
| Grazi, P | 1 |
| Ruffini, M | 1 |
| Pinelli, G | 1 |
| Dalen, JE | 2 |
| Harker, LB | 1 |
| Salzman, EW | 1 |
| Kilpeläinen, H | 1 |
| Penttilä, I | 1 |
| Ferlito, S | 1 |
| Stachenko, SJ | 1 |
| Bravo, G | 1 |
| Côté, R | 1 |
| Boucher, J | 1 |
| Battista, RN | 1 |
| Penttilä, IM | 1 |
| Kutner, M | 1 |
| Nixon, G | 1 |
| Silverstone, F | 1 |
| Fratiglioni, L | 1 |
| Baldereschi, M | 1 |
| Candelise, L | 1 |
| Anzalone, N | 1 |
| Bonatti, ML | 1 |
| Prencipe, M | 1 |
| Gandolfo, C | 1 |
| Mamoli, A | 1 |
| Rasura, M | 1 |
| Icenogle, TB | 1 |
| Smith, RG | 1 |
| Cleavinger, M | 1 |
| Vasu, MA | 1 |
| Williams, RJ | 1 |
| Sethi, GK | 1 |
| Copeland, JG | 1 |
| Joseph, R | 2 |
| Welch, KM | 2 |
| D'Andrea, G | 2 |
| Belcaro, G | 1 |
| Errichi, BM | 1 |
| Laurora, G | 1 |
| Marinucci, R | 1 |
| Cesarone, MR | 1 |
| De Cenzo, A | 1 |
| Oster, SB | 1 |
| Baudoin, C | 1 |
| Alijotas Reig, J | 1 |
| Sze, PC | 1 |
| Reitman, D | 1 |
| Pincus, MM | 1 |
| Sacks, HS | 1 |
| Chalmers, TC | 1 |
| Matías-Guiu, J | 1 |
| Dávalos, A | 1 |
| Picó, M | 1 |
| Monasterio, J | 1 |
| Vilaseca, J | 1 |
| Codina, A | 1 |
| Pinna, AD | 1 |
| Argiolu, F | 1 |
| Marongiu, L | 1 |
| Pinna, DC | 1 |
| Freeman, JW | 1 |
| Lecompte, T | 1 |
| Samama, M | 1 |
| Colwell, JA | 2 |
| Bingham, SF | 2 |
| Rosenthal, D | 1 |
| Lamis, PA | 1 |
| Stanton, PE | 1 |
| Clark, MD | 1 |
| Ellison, RG | 1 |
| David, JL | 1 |
| Kasuya, A | 1 |
| Holm, K | 1 |
| Ishchenko, MM | 1 |
| Shkrobot, SI | 1 |
| Ishchenko, AM | 1 |
| Geeraert, AJ | 1 |
| Al Saigh, AH | 1 |
| Findlay, JM | 1 |
| Lougheed, WM | 1 |
| Gentili, F | 1 |
| Walker, PM | 1 |
| Glynn, MF | 1 |
| Houle, S | 1 |
| Abraira, C | 1 |
| Anderson, JW | 1 |
| Kwaan, HC | 1 |
| Cutler, BS | 1 |
| Eriksson, SE | 1 |
| Loeliger, EA | 1 |
| Yoshii, K | 1 |
| Seki, Y | 1 |
| Aiba, T | 1 |
| Tsukada, T | 1 |
| Shiozawa, R | 1 |
| Marc-Vergnes, JP | 1 |
| Bes, A | 1 |
| Charlet, JP | 1 |
| Delpla, M | 1 |
| Richardot, JP | 1 |
| Géraud, J | 2 |
| Cantu, RC | 1 |
| Snyder, M | 1 |
| De Sando, T | 1 |
| Franchi, L | 1 |
| Neri, R | 1 |
| Colonna, S | 1 |
| Cannata, P | 1 |
| Biagi, G | 1 |
| Kazmier, FJ | 1 |
| Rascol, A | 1 |
| Bierme, R | 1 |
| Boneu, B | 1 |
| Guiraud, B | 1 |
| Fernet, P | 1 |
| Géraud, G | 1 |
| David, J | 1 |
| Danta, G | 3 |
| Millikan, CH | 1 |
| Acheson, J | 1 |
| Hutchinson, EC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Technical Development for Pediatric Cardiovascular MRI[NCT02892136] | 5,000 participants (Anticipated) | Observational | 2013-05-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
55 reviews available for dipyridamole and Brain Vascular Disorders
| Article | Year |
|---|---|
[Anticoagulants of primary haemostasis].
Topics: Anticoagulants; Cardiovascular Diseases; Cerebrovascular Disorders; Dipyridamole; Hemostasis; Humans | 2009 |
Heterogeneity of efficacy and safety of antiplatelet therapy in cardiovascular and cerebrovascular disease.
Topics: Acute Coronary Syndrome; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trial | 2010 |
Antiplatelet therapy in cerebrovascular disorders.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Humans; Platelet Aggr | 2012 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ische | 2003 |
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopido | 2004 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ische | 2006 |
Prevention of vascular events in patients with cerebrovascular disease: efficacy and appropriate duration of antiplatelet therapy.
Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Pl | 2006 |
Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Ische | 2007 |
Antiplatelet agents: rationale and results.
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Animals; Arachidonic Acids; Aspirin; Blood Plate | 1983 |
[Role of antiaggregant platelet drugs in thromboembolism].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Bacterial Agents; Aspirin; Cerebrova | 1981 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
Current therapy of cerebrovascular disease.
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Ische | 1984 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofib | 1983 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggrega | 1983 |
Therapy of ischemic cerebral vascular disease due to atherothrombosis. (2).
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Basilar Artery; Blood Platelets; | 1984 |
Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
Topics: Angina Pectoris; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Thrombosi | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Dise | 1980 |
[Prevention of thrombosis by thrombocyte inhibition. 2. Clinical results].
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofibrate; Dextrans; | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
Antiplatelet therapy.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyridamole; Hea | 1981 |
Secondary prevention of stroke: does dipyridamole add to aspirin?
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Randomized Cont | 1994 |
[Advances in prophylactic treatment of cerebrovascular diseases].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Endarterectomy, Carotid; Humans | 1994 |
The role of dipyridamole in stroke prevention.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; | 1996 |
[Large trials in the secondary prevention of stroke].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Cost-Benefit Analysis; | 1996 |
[Secondary prevention following cerebral ischemia: is monotherapy with acetylsalicylic acid still first choice?].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Cerebrovascular Disorders; Clopidogrel | 1998 |
Do we still need dipyridamole?
Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhib | 1998 |
Antiplatelet drugs in secondary prevention of stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Huma | 1998 |
Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results.
Topics: Aspirin; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Dipyridamole; Drug Therapy, | 1998 |
Dipyridamole trials in stroke prevention.
Topics: Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomized Control | 1998 |
Clinical considerations in selecting antiplatelet therapy in cerebrovascular disease.
Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibito | 1998 |
Antiplatelet agents and stroke prevention.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipy | 1998 |
Antiplatelet therapy for secondary stroke prevention.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therap | 1999 |
Dipyridamole plus aspirin in cerebrovascular disease.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combinatio | 1999 |
Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Humans; Pla | 2000 |
Analysis of trials evaluating combinations of acetylsalicylic acid and dipyridamole in the secondary prevention of stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; I | 2001 |
Actions and clinical status of platelet-suppressive agents.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Heart Valve Dis | 1978 |
Platelet function inhibitors: their clinical use.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease | 1978 |
Platelet suppressive therapy.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Coro | 1978 |
[Treatment with antiplatelet drugs. Current status of knowledge].
Topics: Aspirin; Blood Platelet Disorders; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dextrans | 1979 |
Antiplatelet agents: a review.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Clofi | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Platelets and thromboembolism.
Topics: Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clofibrate; Dext | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
Aspirin and other platelet-active drugs. The relationship between dose, effectiveness, and side effects.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Dose-Response Relationship, Drug; | 1992 |
Antiplatelet therapy in the prevention of stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Randomize | 1991 |
[Platelet antiaggregants in the treatment of arterial thrombosis].
Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Cerebrovascular Disorders; Coronary Artery | 1991 |
Aspirin in transient ischemic attacks and minor stroke: a meta-analysis.
Topics: Adult; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; | 1991 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; | 1990 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
The management of TIAs in 1986.
Topics: Arterial Occlusive Diseases; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Dipyridamo | 1986 |
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1986 |
Management of thrombotic diseases.
Topics: Anticoagulants; Aspirin; Blood Coagulation; Blood Platelets; Cerebrovascular Disorders; Coronary Dis | 1971 |
Platelet inhibition in the management of thrombosis.
Topics: Aspirin; Blindness; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dextrans; Dipyridamol | 1974 |
53 trials available for dipyridamole and Brain Vascular Disorders
| Article | Year |
|---|---|
A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
Topics: Adrenergic beta-Antagonists; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cerebrovascula | 1980 |
Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Artery Bypas | 1982 |
[Controlled cooperative trial of secondary prevention of cerebral ischemic accidents caused by atherosclerosis, using aspirin and dipyridamole].
Topics: Aged; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; | 1983 |
[Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dihydroergotoxine; Dipyri | 1983 |
[Place of antiplatelet agents in the prevention of cerebral ischemic strokes].
Topics: Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Clofib | 1983 |
Doubts about dipyridamole as an antithrombotic drug.
Topics: Antithrombins; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Humans; Myocardial | 1984 |
Prevention of stroke.
Topics: Aged; Aspirin; Canada; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Female; He | 1984 |
Dipyridamole: a critical evaluation.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1984 |
Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
Topics: Animals; Anticoagulants; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coronary Dise | 1980 |
Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
Topics: Adult; Aged; Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials a | 1980 |
The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Topics: Aspirin; Blood Pressure; Blood Urea Nitrogen; Cerebrovascular Disorders; Clinical Trials as Topic; C | 1980 |
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
Topics: Adult; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Di | 1981 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1981 |
Plafibride: clinical trial of a new platelet antiaggregating agent.
Topics: Adenosine Diphosphate; Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Clofibrate; Clofib | 1981 |
Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Collagen; Coronary Disease; Dipyridamo | 1981 |
Antiplatelet therapy and cerebrovascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Double- | 1982 |
Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes.
Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind | 1995 |
European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly.
Topics: Actuarial Analysis; Aged; Aspirin; Cause of Death; Cerebral Infarction; Cerebrovascular Disorders; D | 1993 |
[2nd European study on secondary prevention of stroke (ESPS 2). Respective roles of acetylsalicylic acid, dipyridamole and their combination].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggreg | 1995 |
Second European Stroke Prevention Study.
Topics: Aspirin; Cerebrovascular Disorders; Delayed-Action Preparations; Dipyridamole; Humans | 1996 |
European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Demography; Dipyridamole; Double-Blind Method; Fema | 1996 |
[Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors].
Topics: Arteriosclerosis; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Dose-Response Re | 1996 |
European Stroke Prevention Study 2. Efficacy and safety data.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Data Interpretation, Statistical; Delayed-Action Preparati | 1997 |
European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Disease-Free Survival; Double-Blind Method; | 1997 |
European Stroke Prevention Study-2 results: serendipitous demonstration of neuroprotection induced by endogenous adenosine accumulation?
Topics: Adenosine; Aspirin; Blood-Brain Barrier; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Comb | 1998 |
Up to date review of the secondary preventive measures for recurrent ischaemic stroke and transient ischaemic episodes.
Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Hu | 1998 |
Risk factors and antiplatelet therapy in TIA and stroke patients.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Eu | 1998 |
[Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].
Topics: Adult; Aged; Anticoagulants; Antifibrinolytic Agents; Aspirin; Brain Ischemia; Cerebrovascular Disor | 1998 |
Efficacy of antiplatelet treatment in hypertensive patients with TIA or stroke.
Topics: Aspirin; Blood Pressure; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therapy, | 1998 |
Secondary stroke prevention with low-dose aspirin, sustained release dipyridamole alone and in combination. ESPS Investigators. European Stroke Prevention Study.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Delayed-Action Preparations; Dipyridamole; Disease-Free Su | 1998 |
Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aspirin; Brain Ischemia; Cerebrovascular Disorders; | 1999 |
[Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Humans; | 1999 |
Does aspirin prevent stroke?
Topics: Anticoagulants; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyr | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
The current status of platelet suppressive drugs in the treatment of thrombosis.
Topics: Aged; Arteriovenous Shunt, Surgical; Aspirin; Blood Platelets; Cardiac Catheterization; Cell Surviva | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (first of three parts).
Topics: Animals; Antidepressive Agents, Tricyclic; Aspirin; Blindness; Blood Platelets; Cerebrovascular Diso | 1975 |
European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus; Dipyridamole; D | 1992 |
Antiplatelet therapy is effective in the prevention of stroke or death in women: subgroup analysis of the European Stroke Prevention Study (ESPS).
Topics: Aspirin; Cause of Death; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; | 1991 |
The European Stroke Prevention Study: results according to sex.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Ischemic Attack, Transient; Male; | 1991 |
The European Stroke Prevention Study (ESPS): results by arterial distribution.
Topics: Aspirin; Carotid Arteries; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Drug Therap | 1991 |
Secondary prevention of myocardial infarction in the first European Stroke Prevention Study.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Europe; Humans; Myocard | 1990 |
[Study Group: "Evaluation of the efficacy of therapeutic treatments in cerebrovascular diseases"].
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Double-Blind Method; Female; | 1990 |
European Stroke Prevention Study. ESPS Group.
Topics: Age Factors; Aspirin; Brain Ischemia; Carotid Artery Diseases; Cerebrovascular Disorders; Clinical T | 1990 |
Thromboembolic complications of the Symbion AVAD System.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Equipment Design; Heart-Assist De | 1989 |
The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group.
Topics: Actuarial Analysis; Aspirin; Capsules; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyrida | 1987 |
Secondary prevention of strokes: role of platelet antiaggregant drugs in diabetic and non-diabetic patients.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Diabetic Angiopathies; Dipyridamole; D | 1985 |
Antiplatelet agents in the secondary prevention of stroke: meta-analysis of the randomized control trials.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Drug Combinations; Human | 1988 |
Low-dose acetylsalicylic acid (ASA) plus dipyridamole versus dipyridamole alone in the prevention of stroke in patients with reversible ischemic attacks.
Topics: Adult; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; D | 1987 |
A critical appraisal of the clinical efficiency of anti-platelet drugs.
Topics: Angina Pectoris; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1986 |
VA cooperative study on antiplatelet agents in diabetic patients after amputation for gangrene. IV. Issues in design, interpretation, and analysis.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1986 |
Effect of perioperative platelet inhibition on postcarotid endarterectomy mural thrombus formation. Results of a prospective randomized controlled trial using aspirin and dipyridamole in humans.
Topics: Aged; Aspirin; Blood Platelets; Carotid Arteries; Carotid Artery Diseases; Cerebrovascular Disorders | 1985 |
V.A. Cooperative Study on antiplatelet agents in diabetic patients after amputation for gangrene: III. Definitions and review of design and baseline characteristics.
Topics: Amputation, Surgical; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; | 1985 |
Controlled trial of dipyridamole in cerebral vascular disease.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Female; Headache; Humans; Ischemi | 1969 |
73 other studies available for dipyridamole and Brain Vascular Disorders
| Article | Year |
|---|---|
[Thromboprophylaxis for cerebrovascular disorders: acetylsalicylic acid remains the cornerstone].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Hu | 2008 |
Oral antiplatelet therapy.
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; | 2005 |
Antiplatelet drugs in the secondary prevention after stroke: differential efficacy in large versus small vessel disease? A subgroup analysis from ESPS-2.
Topics: Aged; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Male; Middle | 2006 |
Antithrombotic treatment.
Topics: Ancrod; Aspirin; Cerebrovascular Disorders; Dextrans; Dipyridamole; Drug Administration Schedule; He | 1983 |
Antiplatelet drugs.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Disease; Dextrans; Dipyridamole; Epopr | 1983 |
Prognostic value of beta-thromboglobulin in patients with transient cerebral ischaemia.
Topics: Adult; Age Factors; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Cerebrovas | 1983 |
Surgical management of the occluded carotid artery.
Topics: Adult; Aged; Arterial Occlusive Diseases; Aspirin; Carotid Arteries; Carotid Artery Diseases; Cerebr | 1984 |
The lame brain at the crossroads: which therapeutic road?
Topics: Aged; Aspirin; Carotid Artery Diseases; Cerebral Infarction; Cerebrovascular Disorders; Dipyridamole | 1984 |
Drugs in the treatment of thrombo-embolic disease--part I.
Topics: Administration, Oral; Anticoagulants; Aspirin; Blood Platelets; Carotid Artery Diseases; Cerebrovasc | 1983 |
Use of common antiplatelet drugs for vascular diseases.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Coronary Artery Bypass; Coronary Disease; Couma | 1983 |
Transient ischemic attacks. Strategies for minimizing stroke risk.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Ischemic Attack, Transient; Middle A | 1984 |
[Conservative therapy of stroke from an internist's viewpoint].
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Digitalis Glycosides; Dipyridamole; Diuretics; H | 1983 |
Management of transient cerebral ischaemic attacks by hospital doctors in Scotland.
Topics: Anticoagulants; Aspirin; Carotid Arteries; Cerebrovascular Disorders; Dipyridamole; Female; Humans; | 1983 |
[Present situation of therapy with platelet aggregation inhibitors].
Topics: Adult; Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Middle Aged; | 1982 |
[Ischemic cerebro-vascular accidents: usefulness of anticoagulant and antiaggregating agents (author's transl)].
Topics: Aged; Anticoagulants; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Humans; Plat | 1981 |
For your stroke-prone patients: a guide to drug treatment.
Topics: Aged; Antihypertensive Agents; Aspirin; Brain Diseases; Cerebral Angiography; Cerebrovascular Disord | 1980 |
Safety of dipyridamole testing in patients with cerebrovascular disease.
Topics: Aged; Cerebrovascular Disorders; Dipyridamole; Female; Hemodynamics; Humans; Ischemic Attack, Transi | 1995 |
Transient neurological events during dipyridamole stress test: an arterial steal phenomenon?
Topics: Aged; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Exercise; Hand Strength; Heart; Hum | 1994 |
Dipyridamole testing in cerebrovascular patients.
Topics: Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Humans; Radionuclide Imaging | 1993 |
Cerebrovascular accident associated with dipyridamole thallium-201 myocardial imaging: case report.
Topics: Cerebrovascular Disorders; Dipyridamole; Heart; Humans; Injections, Intravenous; Male; Middle Aged; | 1993 |
In vivo evaluation of antiplatelet agents in gerbil model of carotid artery thrombosis.
Topics: Animals; Aspirin; Carotid Artery Diseases; Carotid Artery Injuries; Carotid Artery, Common; Cerebrov | 1996 |
Critique of two putative therapies in stroke prevention using platelet inhibitors.
Topics: Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Ticlopidine | 1996 |
Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
Topics: Apolipoproteins A; Biomarkers; Blood Glucose; Blood Pressure; Cerebrovascular Disorders; Cholesterol | 1997 |
Fraud and ethics charges hit stroke drug trial.
Topics: Aspirin; Brain Diseases; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Dipyridamol | 1996 |
CAPRIE trial.
Topics: Aspirin; Cerebrovascular Disorders; Clopidogrel; Cost-Benefit Analysis; Dipyridamole; Humans; Platel | 1997 |
Aspirin and stroke.
Topics: Aspirin; Cerebrovascular Disorders; Controlled Clinical Trials as Topic; Dipyridamole; Drug Therapy, | 1997 |
Antiplatelet therapy in ischaemic events.
Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; Humans; Platelet Aggregation Inhi | 1997 |
Inappropriate practices in prescribing: who decides and how.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Prescriptions; Drug Therapy, Combinatio | 1997 |
Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation Inhib | 1997 |
Secondary prevention of stroke--new trials.
Topics: Aged; Aspirin; Cerebrovascular Disorders; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Dr | 1998 |
[An acetylsalicylic acid-dypiridamole combination (Asasantine) in the prevention of the recurrence of cerebrovascular accidents (a cost-effectiveness analysis)].
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Belgium; Cerebrovascular Disorders; Cost-Benefit An | 1998 |
[Prevention of thrombosis after ischemic cerebrovascular attack--new possibilities].
Topics: Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Humans; Intracranial Embolism | 1998 |
[Thrombosis prophylaxis after cerebrovascular attack].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Intracranial Embolism and Thrombosis; Plat | 1998 |
Aspirin and dipyridamole for the secondary prevention of stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinations; Humans; Meta-Analysis as Topic; | 1999 |
Secondary stroke prevention with drugs: single or combined therapy?
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Clopidogrel; Dipyridamole; Drug Therapy, Combina | 1999 |
[Dipyridamole plus acetylsalicylic acid--who is to be trusted?].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Hu | 1999 |
Dipyridamole plus aspirin in cerebrovascular disease.
Topics: Aspirin; Aspirin, Dipyridamole Drug Combination; Cerebrovascular Disorders; Clinical Trials as Topic | 2000 |
Is treatment with aspirin combined with dipyridamole really more cost-effective than aspirin alone?
Topics: Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Cost-Benefit Analysis; Dipyridamole; D | 2001 |
Platelet activation in acute cerebral ischaemia. Serial measurements of platelet function in cerebrovascular disease.
Topics: Acute Disease; Adenosine Diphosphate; Aged; Aspirin; Blood Cell Count; Blood Platelets; Cerebrovascu | 1977 |
[Anti-platelet aggregating drugs in the prevention of thromboembolic diseases].
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cardiovascular Diseases; Cerebrovascular Diso | 1975 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders | 1979 |
Role of antiplatelet agents in cerebrovascular disease.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Humans; Plat | 1979 |
TIA, stroke, and mitral valve prolapse.
Topics: Adult; Aged; Aspirin; Carotid Artery Thrombosis; Cerebrovascular Disorders; Dipyridamole; Echocardio | 1979 |
The role of the platelet in coagulation and clinical thrombotic events.
Topics: Blood Coagulation; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Dipy | 1977 |
Anticoagulants and platelet-inhibiting drugs in stroke.
Topics: Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Platelet Aggregation; Sulf | 1977 |
Using antithrombotic therapy in ischemic cerebrovascular disease.
Topics: Aspirin; Brain; Cerebrovascular Disorders; Dipyridamole; Fibrinolytic Agents; Heparin; Humans; Intra | 1977 |
Prevention of stroke.
Topics: Age Factors; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Auscultation; Cerebral Angiograph | 1975 |
Heart-brain interactions in cerebral ischaemia: a non-invasive cardiologic study protocol.
Topics: Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Echocardiography; Electro | 1992 |
Atrial fibrillation and embolic stroke.
Topics: Aged; Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Dipyridamole; Embolism; Humans; Warfa | 1991 |
Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation.
Topics: Administration, Oral; Aged; Aspirin; Atrial Fibrillation; Attitude of Health Personnel; Cerebrovascu | 1991 |
Effect of therapy on platelet activating factor-induced aggregation in acute stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; P | 1989 |
[Chronic treatment of vascular diseases with indobufen].
Topics: Adult; Aged; Aspirin; Cerebrovascular Disorders; Dipyridamole; Humans; Isoindoles; Middle Aged; Phen | 1989 |
Whole blood platelet function in acute ischemic stroke. Importance of dense body secretion and effects of antithrombotic agents.
Topics: Acute Disease; Adult; Aspirin; Blood Platelets; Brain Ischemia; Cerebrovascular Disorders; Dipyridam | 1989 |
Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
Topics: Angina Pectoris; Angina, Unstable; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Combinatio | 1988 |
[Risk factors and antiaggregant treatment in cerebrovascular diseases].
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Blood Coagulation Factors; Cerebrovascular Disorders; Dipyr | 1988 |
Indications and results for splenectomy for beta thalassemia in two hundred and twenty-one pediatric patients.
Topics: Aspirin; Blood Transfusion; Cerebrovascular Disorders; Child; Dipyridamole; Female; Follow-Up Studie | 1988 |
Prevention of postoperative neurologic deficits after carotid endarterectomy. Is platelet inhibition beneficial?
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carotid Artery Diseases; Cerebrovascular Disorders; Dipyrid | 1987 |
[Mode of action and clinical evaluation of platelet aggregation inhibitors].
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Graft Occlusion, Vascular; Humans; Ketanserin; Myo | 1987 |
Pharmacologic approach to ischemic stroke management.
Topics: Aspirin; Blood Platelets; Cerebrovascular Disorders; Dipyridamole; Drug Interactions; Heparin; Human | 1986 |
[Curantyl treatment of patients with atherosclerosis and chronic cerebral circulatory insufficiency].
Topics: Adult; Aged; Arteriosclerosis; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Male; Middle | 1986 |
Spontaneous dissection of the carotid artery: an unusual cause of stroke in younger patients.
Topics: Adult; Aspirin; Carotid Artery Diseases; Carotid Artery, Internal; Cerebral Angiography; Cerebrovasc | 1987 |
Prevention of cardiac complications in peripheral vascular surgery.
Topics: Angiography; Arrhythmias, Cardiac; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Electr | 1986 |
Enteric-coated acetylsalicylic acid plus dipyridamole compared with anticoagulants in the prevention of ischemic events in patients with transient ischemic attacks.
Topics: Aged; Anticoagulants; Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; F | 1985 |
Does dipyridamole have antithrombotic potential?
Topics: Aspirin; Cerebrovascular Disorders; Coronary Disease; Dipyridamole; Humans; Myocardial Infarction; P | 1985 |
[Anti-platelet therapy in ischemic cerebrovascular disorder--clinical and hematological study].
Topics: Adult; Aged; Aspirin; Blood Platelets; Cell Survival; Cerebrovascular Disorders; Dipyridamole; Femal | 1985 |
Glycerol and stroke.
Topics: Brain Edema; Cerebrovascular Disorders; Dipyridamole; Drug Synergism; Glycerol; Humans; Oxidative Ph | 1973 |
[Pharmacodynamics of the cerebral circulation. Results of a study on the action of 10 drugs on cerebral blood flow and energy metabolism in cerebrovascular patients].
Topics: Adult; Aged; Brain; Cerebrovascular Circulation; Cerebrovascular Disorders; Dipyridamole; Ergoloid M | 1974 |
Effect of anticoagulants, vasodilators, and dipyridamole on postischemic cerebral vascular obstruction.
Topics: Amino Alcohols; Animals; Anticoagulants; Bicarbonates; Cerebrovascular Disorders; Dipyridamole; Ethy | 1972 |
[Synergism of action of dipyridamole combined with bamethan administered by intravenous infusion in senile cerebral circulatory disturbances].
Topics: Aged; Cerebrovascular Disorders; Dipyridamole; Drug Combinations; Drug Synergism; Ethanolamines; Fem | 1972 |
[Platelet function disorders and ischemic cerebral accidents. Therapeutic prospects].
Topics: Adult; Aspirin; Blood Coagulation Tests; Blood Platelet Disorders; Cerebrovascular Disorders; Dipyri | 1972 |
Platelet aggregation in patients with cerebral vascular disease and in control subjects.
Topics: Adult; Age Factors; Cerebrovascular Disorders; Chronic Disease; Dipyridamole; Female; Humans; Hymeno | 1973 |
Address of the president-elect: the indication for various methods of treatment of occlusive cerebrovascular disease.
Topics: Anticoagulants; Aspirin; Blood Pressure; Cardiac Output; Carotid Arteries; Cerebral Angiography; Cer | 1973 |
Second phase platelet aggregation induced by adenosine diphosphate in patients with cerebral vascular disease and in control subjects.
Topics: Adenine Nucleotides; Adult; Aged; Blood Platelets; Bronchitis; Carpal Tunnel Syndrome; Cerebrovascul | 1970 |